Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ASH21
Recent news which mentions ASH21
BeyondSpring's New Plinabulin Data Shows Fast Onset In Preventing Chemo-Induced Neutropenia
December 15, 2021
Tickers
BYSI
Tags
BYSI
Market News
Benzinga
From
Benzinga
Global Blood Raises $300M Via Convertible Debt Offering
December 15, 2021
Tickers
GBT
Tags
Sickle Cell Disease
Movers
Briefs
From
Benzinga
Roche's Polivy Combo Boosts Survival In Early-Stage Lymphoma Patients
December 14, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
Briefs
News
ASH21
From
Benzinga
Sanofi Reveals Late-Stage Data For Fitusiran In Hemophilia Patients
December 14, 2021
Tickers
SNY
Tags
Hemophilia A
ASH21
SNY
From
Benzinga
Agios Presents Mitapivat Long-Term Data On Hemoglobin Response, Transfusion Burden
December 14, 2021
Tickers
AGIO
Tags
AGIO
Benzinga
Market News
From
Benzinga
Precigen Reveals Early Data From CAR-T Candidate In Blood Cancer Patients
December 14, 2021
Tickers
PGEN
Tags
Phase 1 Trial
Biotech
Small Cap
From
Benzinga
Atara Bio Unveils Pivotal Data On T Cell Therapy Tabelecleucel In Transplant Patients
December 14, 2021
Tickers
ATRA
Tags
Health Care
Biotech
Small Cap
From
Benzinga
Aptose Shares Fall After HM43239 Data Featured At ASH Annual Meeting, Luxeptinib, APTO-253 Update
December 14, 2021
Tickers
APTO
Tags
Health Care
Biotech
Phase 1 Trial
From
Benzinga
Fate Therapeutics Showcases Interim Data From FT596 Cell Program In Lymphoma
December 14, 2021
Tickers
FATE
Tags
General
Movers
ASH21
From
Benzinga
Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients
December 14, 2021
Tickers
GILD
Tags
Market News
GILD
Phase 2 Trial
From
Benzinga
Syndax Pharma Posts Additional Data On Clinical Activity, Responses From Early-Stage Leukemia Trial
December 14, 2021
Tickers
SNDX
Tags
General
ASH21
Briefs
From
Benzinga
ALX Oncology's Evorpacept Data Fails To Impress At ASH Presentation
December 13, 2021
Tickers
ALXO
Tags
Briefs
why it's moving
News
From
Benzinga
Why Did X4 Pharmaceuticals Shares Crater To 52-Week Low?
December 13, 2021
Tickers
XFOR
Tags
General
why it's moving
Briefs
From
Benzinga
Viracta Therapeutics Posts Data From Lymphoma Trial At ASH Presentation
December 13, 2021
Tickers
VIRX
Tags
lymphoma
ASH21
Briefs
From
Benzinga
Comparing Data: Sanofi Vs. Johnson & Johnson Multiple Myeloma Therapies In Newly Diagnosed Patients
December 13, 2021
Tickers
BMY
JNJ
SNY
TAK
Tags
BMY
Health Care
Biotech
From
Benzinga
Harpoon Shares Jump After Early Data From BCMA-Targeting Myeloma Candidate At ASH Meet
December 13, 2021
Tickers
HARP
Tags
multiple myeloma
HARP
Movers
From
Benzinga
JNJ's Janssen Posts Two Years Survival Data On BCMA Cell Therapy In Multiple Myeloma
December 13, 2021
Tickers
JNJ
LEGN
Tags
LEGN
General
News
From
Benzinga
Jazz Posts New Data for ALL/LBL Treatment At ASH 2021 Annual Meeting
December 13, 2021
Tickers
JAZZ
Tags
Health Care
General
Phase 3 Trial
From
Benzinga
Roche Uncorks Favorable Responses From Mosunetuzumab In Follicular Lymphoma Settings
December 13, 2021
Tickers
RHHBF
RHHBY
RHHVF
Tags
General
RHHBY
ASH21
From
Benzinga
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
December 13, 2021
Tickers
BLUE
Tags
Trading Ideas
Benzinga
Market News
From
Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
December 13, 2021
Tickers
BLUE
Tags
BLUE
ASH21
News
From
Benzinga
Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients
December 13, 2021
Tickers
GILD
Tags
General
Health Care
Phase 3 Trial
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.